Relmada Therapeutics (RLMD) Short Interest Ratio & Short Volume → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free RLMD Stock Alerts $3.49 +0.01 (+0.29%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Relmada Therapeutics Short Interest DataCurrent Short Volume1,640,000 sharesPrevious Short Volume1,710,000 sharesChange Vs. Previous Month-4.09%Dollar Volume Sold Short$5.97 millionShort Interest Ratio / Days to Cover9.4Last Record DateApril 30, 2024Outstanding Shares30,170,000 sharesPercentage of Shares Shorted5.44%Today's Trading Volume43,530 sharesAverage Trading Volume100,813 sharesToday's Volume Vs. Average43% Short Selling Relmada Therapeutics ? Sign up to receive the latest short interest report for Relmada Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRLMD Short Interest Over TimeRLMD Days to Cover Over TimeRLMD Percentage of Float Shorted Over Time Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. Relmada Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,640,000 shares $5.97 million -4.1%N/A9.4 $3.64 4/15/20241,710,000 shares $7.61 million +1.2%N/A8.1 $4.45 3/31/20241,690,000 shares $7.86 million -3.4%N/A7.4 $4.65 3/15/20241,750,000 shares $9.49 million No ChangeN/A5.4 $5.42 2/29/20241,750,000 shares $10.72 million +1.2%N/A5.5 $6.13 2/15/20241,730,000 shares $9.12 million +7.5%N/A5.6 $5.27 Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,610,000 shares $6.33 million +3.2%N/A5.6 $3.93 1/15/20241,560,000 shares $4.90 million +92.4%N/A6.3 $3.14 12/31/2023810,700 shares $3.36 million +26.9%N/A3.3 $4.14 12/15/2023638,800 shares $1.58 million -26.2%N/A3.7 $2.48 11/30/2023865,800 shares $2.14 million -1.1%N/A5.3 $2.47 11/15/2023875,200 shares $2.65 million +10.1%N/A5.6 $3.03 10/31/2023794,700 shares $2.38 million +13.4%N/A5 $2.99 10/15/2023700,900 shares $2.17 million -2.5%N/A4.6 $3.10 9/30/2023718,700 shares $2.16 million +6.1%N/A4.9 $3.00 9/15/2023677,500 shares $2.09 million +9.7%N/A4.5 $3.09 8/31/2023617,700 shares $2.09 million -10.5%N/A3.8 $3.38 8/15/2023689,800 shares $2.35 million -18.8%N/A4.1 $3.41 7/31/2023849,900 shares $2.23 million -11.0%N/A4.8 $2.62 7/15/2023954,400 shares $2.71 million -9.1%N/A5 $2.84 6/30/20231,050,000 shares $2.58 million -46.7%N/A5.2 $2.46 6/15/20231,970,000 shares $5.02 million -5.3%N/A8.7 $2.55 5/31/20232,080,000 shares $5.91 million +16.9%N/A11.3 $2.84 5/15/20231,780,000 shares $5.50 million -3.3%N/A9.1 $3.09 4/30/20231,840,000 shares $4.64 million +0.6%N/A9.1 $2.52 4/15/20231,830,000 shares $4.96 million +4.0%N/A8.5 $2.71 3/31/20231,760,000 shares $3.98 million +13.6%N/A6.6 $2.26 3/15/20231,550,000 shares $3.97 million +6.2%N/A5 $2.56 2/28/20231,460,000 shares $5.26 million -8.8%N/A2.5 $3.60 2/15/20231,600,000 shares $5.94 million No ChangeN/A2.5 $3.71 1/31/20231,600,000 shares $6.50 million -20.4%N/A2.2 $4.06 1/15/20232,010,000 shares $8.28 million +12.3%N/A2.4 $4.12 12/30/20221,790,000 shares $6.25 million +4.1%N/A1.4 $3.49 12/15/20221,720,000 shares $5.40 million -13.6%N/A1.3 $3.14 11/30/20221,990,000 shares $9.25 million -28.2%N/A1.6 $4.65 11/15/20222,770,000 shares $16.32 million -4.2%N/A2.6 $5.89 10/31/20222,890,000 shares $18.47 million -13.7%N/A2.9 $6.39 10/15/20223,350,000 shares $20.77 million -26.2%N/A3.8 $6.20 9/30/20224,540,000 shares $168.07 million +25.1%N/A12.3 $37.02 9/15/20223,630,000 shares $124.84 million +11.7%N/A11.3 $34.39Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… RLMD Short Interest - Frequently Asked Questions What is Relmada Therapeutics' current short interest? Short interest is the volume of Relmada Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,640,000 shares of RLMD short. Learn More on Relmada Therapeutics' current short interest. What is a good short interest ratio for Relmada Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLMD shares currently have a short interest ratio of 9.0. Learn More on Relmada Therapeutics's short interest ratio. Which institutional investors are shorting Relmada Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Relmada Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Relmada Therapeutics' short interest increasing or decreasing? Relmada Therapeutics saw a decrease in short interest in April. As of April 30th, there was short interest totaling 1,640,000 shares, a decrease of 4.1% from the previous total of 1,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Relmada Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Relmada Therapeutics: PMV Pharmaceuticals, Inc. (6.93%), Adicet Bio, Inc. (9.35%), Citius Pharmaceuticals, Inc. (9.07%), Corvus Pharmaceuticals, Inc. (3.69%), Connect Biopharma Holdings Limited (0.06%), Cellectar Biosciences, Inc. (7.85%), Allakos Inc. (6.31%), Rezolute, Inc. (0.78%), Abeona Therapeutics Inc (12.94%), Immunic, Inc. (3.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Relmada Therapeutics stock? Short selling RLMD is an investing strategy that aims to generate trading profit from Relmada Therapeutics as its price is falling. RLMD shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relmada Therapeutics? A short squeeze for Relmada Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLMD, which in turn drives the price of the stock up even further. How often is Relmada Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLMD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PMV Pharmaceuticals Short Interest Adicet Bio Short Interest Citius Pharmaceuticals Short Interest Corvus Pharmaceuticals Short Interest Connect Biopharma Short Interest Cellectar Biosciences Short Interest Allakos Short Interest Rezolute Short Interest Abeona Therapeutics Short Interest Immunic Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLMD) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity